Antigenics Inc. (AGEN)
|
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: |
Articles on Antigenics Inc. (AGEN)
15 articles
Filter by:
Latest Articles Most commented on articlesMost frequent authors on AGEN
- Alan Brochstein(6)
- Fredric Cohen, M.D.(2)
- Kirk Lindstrom(2)
- Centient Biotech Investor(1)
- Notable Calls(1)
Most popular authors
(tracked in watchlists)
- Alan Brochstein(221)
- Notable Calls(112)
- Mike Huckman(74)
- Kirk Lindstrom(29)
- Michael Shulman(9)
Most commented on authors
- Alan Brochstein(15)
- Michael Shulman(6)
- Notable Calls(4)
- Kirk Lindstrom(4)
- Mike Huckman(4)
- Antigenics: Insider Buying Alert
- Evaluating Cancer Drugs at the FDA
- Antigenics, Dendreon and Cell Genesys Find Hope in Overseas Treatment Approvals
- Antigenics' Cancer Treatment Approved: Here's to Long-Term Success
- Russian Roulette Pays Off for Antigenics
- World's First Cancer Vaccine Approved; Expect Interest in Antigenics, Dendreon
- Is Antigenics a Good Buy Right Now?
- Cancer Stocks: The Bleeding Slows
- Cancer Stocks Hammered Once Again
- Cancer Stocks Slide Again
- Cancer Stocks Plunge Following ASCO Meeting
- Cancer Stocks Soar With Annual ASCO Meeting
- Cancer Stocks on the Go: Winners and Losers
- Biotech Week In Review: Positive Territory For 2007
- Analysing Antigenics' Trial Failure (AGEN)
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »